APA (7th ed.) Citation

EZ, S., JMH, S., J, T., EM, D., SL, J., LF, v. B., . . . NI, M. (2025). Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development. NPJ vaccines, 10(1), 70. https://doi.org/10.1038/s41541-025-01125-w

Chicago Style (17th ed.) Citation

EZ, Siegal, et al. "Risk Analysis for Outpatient Experimental Infection as a Pathway for Affordable RSV Vaccine Development." NPJ Vaccines 10, no. 1 (2025): 70. https://doi.org/10.1038/s41541-025-01125-w.

MLA (9th ed.) Citation

EZ, Siegal, et al. "Risk Analysis for Outpatient Experimental Infection as a Pathway for Affordable RSV Vaccine Development." NPJ Vaccines, vol. 10, no. 1, 2025, p. 70, https://doi.org/10.1038/s41541-025-01125-w.